Epidemiology & Risk Factors

Etiology: Normal physiologic adaptation post-birth.
- Transition to extrauterine life -> ↑ arterial oxygen tension ( $P a O_{2}$ ) -> downregulation of EPO production -> transient cessation of erythropoiesis. c
- Compounded by shortened neonatal RBC lifespan (~60–90 days vs 120 days in adults) and rapid body/blood volume expansion.
Timing: Nadir occurs at 6–9 weeks of life in healthy term infants.
Incidence: Universal in term neonates (normal developmental phenomenon).

Clinical Features

History:
- Asymptomatic (normal feeding, active, alert, normal weight gain).
Physical Examination:
- Normal vital signs.
- Mild pallor may be present at nadir, but infant remains vigorous.
- No jaundice, no hepatosplenomegaly (HSM), no signs of heart failure (no tachypnea, grunting, or hepatomegaly).

Initial/Screening: CBC with differential.
- Hb: Typically nadirs at 9.0–11.0 g/dL (rarely <9 g/dL in term infants).
- MCV: Normal for age (normocytic, normochromic). c
Key Labs:
- Reticulocyte count: Low / inappropriately suppressed for the degree of anemia (due to low EPO levels).
- Peripheral Blood Smear (PBS): Normocytic, normochromic RBCs; no schistocytes, spherocytes, or sickled cells.
- Direct Antiglobulin Test (DAT/Coombs): Negative.
- Total & Direct Bilirubin: Normal (rules out active hemolysis).
Confirmatory/Gold Standard: Clinical diagnosis of exclusion; confirms spontaneously as Hb rises after 8–12 weeks of life.

Anemia of Prematurity:
- Diff by preterm birth (<37 wks), earlier/deeper nadir (Hb 7–9 g/dL at 4–8 wks), often symptomatic (apnea, bradycardia, poor feeding).
Hemolytic Disease of the Newborn (ABO/Rh Incompatibility):
- Diff by presentation in first 24–48 hours of life, ↑ indirect bilirubin (jaundice), (+) DAT/Coombs, and ↑ reticulocytes.
Iron Deficiency Anemia (IDA):
- Diff by onset >6 months in term infants (neonatal iron stores last 4–6 months), microcytic hypochromic (↓ MCV), ↑ RDW, ↓ ferritin.
Diamond-Blackfan Anemia:
- Diff by severe macrocytic/normocytic anemia in early infancy, reticulocytopenia, and congenital anomalies (triphalangeal thumbs, cleft palate, short stature, webbed neck).
Perinatal Blood Loss (e.g., Feto-maternal hemorrhage, vasa previa, subgaleal hemorrhage):
- Diff by acute presentation at birth (pallor, shock) or early days; ↑ reticulocyte response within days.

First-line: Reassurance and Observation.
- No treatment or diagnostic workup required in asymptomatic term infants.
- Normal feeding patterns should continue.
Iron Supplementation:
- Not indicated for treating physiologic anemia (iron stores are adequate; iron does not stimulate EPO).
- Routine nutritional iron supplementation: Begin at 4 months of age (1 mg/kg/day) for exclusively breastfed term infants until iron-rich solids are introduced.
Transfusion:
- Contraindicated/Not indicated for physiologic anemia.

Iatrogenic: Unnecessary testing or inappropriate blood transfusions due to misinterpretation of normal physiologic parameters.
Prognosis: Excellent; resolves spontaneously by 3–6 months of age as tissue oxygen demand rises and endogenous renal EPO production resumes.

tags	—
aliases